EV PD-L1 is correlated with clinical features and contributes to T cell suppression in pediatric thyroid cancer.

Like Comment
The contribution of blood extracellular vesicular (EV) programmed death-ligand 1 (PD-L1) and programmed death-1 (PD-1) in papillary thyroid cancer (PTC) is uncertain.We sought to determine the relationship of EV PD-L1/PD-1 with the clinical features of pediatric PTC and the role of EV PD-L1 in immunosuppression.Plasma levels of EV and soluble PD-L1 and PD-1 and levels of plasma cytokines in PTC children and controls were determined by ELISA. Levels of tumor PD-L1 and the tumor-infiltrating lymphocyte (TIL) score were determined by immunohistochemistry. Correlations of the plasma PD-L1/PD-1 level with clinicopathological characteristics, levels of plasma cytokines, tumor PD-L1 expression and TIL score were analyzed. T cell suppression by EVs from PTC patients was determined by incubation of PD-L1high or PD-L1low EVs with activated CD8+ T cells. Changes in CD69 and PD-1 expression and changes in TNFa and IFNγ secretion were measured by flow cytometry.The levels of plasma PD-L1/PD-1 were significantly higher in PTC children than in controls. The levels of plasma EV PD-L1 significantly correlated with tumor T stage, tumor PD-L1 expression, TIL score, and plasma cytokine content. Levels of plasma soluble PD-1 significantly correlated with patient age, plasma EV PD-L1 and IFNα concentration. PD-L1high EVs significantly inhibited the activation of CD8+ T cells.Plasma levels of EV PD-L1, but not soluble PD-L1, were associated with tumor T stage in PTC children. Plasma EV PD-L1 emerges as a useful metric for assessing tumor T stage and T cell suppression in PTC.


Click here to read the full article @ The Journal of clinical endocrinology and metabolism
Go to the profile of ClinOwl

ClinOwl

The wider, wiser view for healthcare professionals. ClinOwl signposts the latest clinical content from over 100 leading medical journals.
1805 Contributions
1 Followers
0 Following

No comments yet.